Literature DB >> 7838008

Are neuropsychiatric manifestations of folate, cobalamin and pyridoxine deficiency mediated through imbalances in excitatory sulfur amino acids?

C R Santhosh-Kumar1, K L Hassell, J C Deutsch, J F Kolhouse.   

Abstract

Folate, cobalamin and pyridoxine deficiency are associated with psychiatric or neurological symptomatology. Disturbances in sulfur amino acid metabolism leading to accumulation of homocysteine occurs in all three conditions as the metabolism of homocysteine depends on enzymes requiring these vitamins as cofactors. Oxidation products of homocysteine (homocysteine sulfinic acid and homocysteic acid) and cysteine (cysteine sulfinic acid and cysteic acid) are excitatory sulfur amino acids and may act as excitatory neurotransmitters, whereas taurine and hypotaurine (decarboxylation products of cysteic acid and cysteine sulfinic acid) may act as inhibitory transmitters. Homocysteic acid and cysteine sulfinic acid have been considered as endogenous ligands for the N-methyl-D-aspartate (NMDA) type of glutamate receptors. The profile of these sulfur amino acid neurotransmitters could be altered in a similar fashion in states of decreased availability of folate, cobalamin or pyridoxine. It is proposed that the mechanism of neuropsychiatric manifestations in all three conditions result from a combination of two insults to homocysteine catabolism in the brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838008     DOI: 10.1016/0306-9877(94)90073-6

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  A forgotten lethal psychosis: a case report.

Authors:  Diego Hidalgo Mazzei; Sergio Martín Rodriguez; Hipólito Pérez Moltó; Jessica Ruíz Izquierdo; Inmaculada Baeza
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-06-29       Impact factor: 4.785

2.  Vitamin B12 status in patients of Turkish and Dutch descent with depression: a comparative cross-sectional study.

Authors:  Yener Güzelcan; Peter van Loon
Journal:  Ann Gen Psychiatry       Date:  2009-08-13       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.